PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-09-28

Date Title Company
28-Sep-2020 Direct Fed Microbial Market Growing At A CAGR Of 7.5% And To Target $1.77 Billion By 2026 Wired Release
28-Sep-2020 Life Science Analytics Software Market To See Record Break Revenue $16.04 billion By 2027 Wired Release
28-Sep-2020 Fundación MEDINA, DNDi and Institut Pasteur Korea Announce New Funding from “La Caixa” Health Research for Research Partnership to Discover New Natural Products Against Leishmaniasis and Chagas Disease B3C newswire
28-Sep-2020 Relief Announces Capital Increase from its Final Tranche of the Share Subscription Facility with GEM Relief Therapeutics Holdings AG
28-Sep-2020 Phosphine Ligands Now Accessible at Alfa Chemistry Catalysts Alfa Chemistry Catalysts
28-Sep-2020 Alfa Chemistry Testing Lab Publishes Whitepapers for Varieties of Analytical Testing Services Alfa Chemistry Testing Lab
28-Sep-2020 Protheragen Launches Intermediary Services for Biotechnology and Drug R&D Companies Protheragen
28-Sep-2020 Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX Qiming Venture Partners
28-Sep-2020 Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX Qiming Venture Partners
28-Sep-2020 TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC) Innovent Biologics, Inc.
28-Sep-2020 TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC) Innovent Biologics, Inc.